Comparison of time to clinically meaningful improvement in quality of life in neurological disorders in patients treated with natalizumab versus ocrelizumab

MS Treatments

Jahr

Publikationsjahr
2024

Autoren

Autorenliste der Publikation
Hersh CM, Pang M, Miller DM, McGinley MP, Hyland M, Ziemssen T, Avila RL.

Verlag

Publisher-Information
Neurodegener Dis Manag. 2024 Apr 16.

Link

Zur Publikation (externer Server)
https://doi.org/10.2217/nmt-2023-0047

Tags

Forschungsthemen
Multiple SkleroseMS Behandlung
TreatmentsMSZ2024